Source: Annual Congress 2011 - ERS Award for Rare Pulmonary Disease Ceremony (supported by GlaxoSmithKline) followed by Clinical Grand Round - an interactive session



Rating:

Share or cite this content

Citations should be made in the following way:
C. Strange (Charleston, United States of America). Reversible dyspnoea in alpha1-antitrypsin deficiency. Annual Congress 2011 - ERS Award for Rare Pulmonary Disease Ceremony (supported by GlaxoSmithKline) followed by Clinical Grand Round - an interactive session

Member's Comments

No comment yet.

Related content which might interest you: Bronchiectasis in alpha1-antitrypsin deficiency Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Exacerbations of symptoms in alpha-1-antitrypsin deficiency in the UK Source: Eur Respir J 2002; 20: Suppl. 38, 203s Year: 2002 Pulmonary administration of alpha1-antitrypsin for the treatment of Alpha1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Monitoring disease progression in severe Alpha1 antitrypsin deficiency Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Diagnosis and management of alpha1-antitrypsin deficiency Source: Breathe 2007; 4: 38-46 Year: 2007 Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome Source: ERJ Open Res, 7 (4) 00496-2021; 10.1183/23120541.00496-2021 Year: 2021 Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 354-360 Year: 2009 Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Persistent chronic cough and vitamin D deficiency Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Exploring the relationship between alpha-1-antitrypsin deficiency and persistent airflow limitation in severe asthma. Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Severe haemoptysis Source: Eur Respir Monogr 2016; 74: 132-150 Year: 2016 Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 a1-antitrypsin deficiency Source: Eur Respir Monogr 2015; 69: 47-84 Year: 2015 Severity of respiratory symptoms in hereditary angioedema Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Effect of danazol on acute phase reactants in patients with PiM, PiMZ and PiZ phenotypes for alpha-1-antitrypsin deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001